Current status of additive solutions for platelets
- 1 January 2012
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 27 (2), 93-98
- https://doi.org/10.1002/jca.21207
Abstract
The storage of platelets in additive solution (PAS) had lagged behind red cell concentrates, especially in North America. The partial or complete removal of anticoagulated plasma and storage of platelet concentrates in AS presents many advantages. The PAS can be formulated to optimize aerobic metabolism or decrease platelet activation, thus abrogating the platelet storage lesion and potentially improving in vivo viability. Plasma removal has been shown to reduce allergic reactions and the plasma harvested could contribute to the available plasma pool for transfusion or fractionation. PAS coupled to pathogen reduction technology results in a platelet product of equivalent hemostatic efficacy to conventionally stored platelets. Given the above, the likely future direction of platelet storage will be in new generation designer PAS with an extended shelf life and a superior safety profile to plasma stored platelets. J. Clin. Apheresis, 2012.Keywords
This publication has 61 references indexed in Scilit:
- Stability of coagulation factors in plasma prepared after a 24‐hour room temperature holdTransfusion, 2010
- I.V. immunoglobulin therapy for infectious diseasesDrug and Therapeutics Bulletin, 2010
- How much residual plasma may cause TRALI?Transfusion Medicine, 2008
- In vitro function of buffy coat‐derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bagsVox Sanguinis, 2007
- In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solutionVox Sanguinis, 2007
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialBlood, 2004
- White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasmaTransfusion, 1995
- In vitro and in vivo effects of prestorage filtration of apheresis plateletsTransfusion, 1995
- Storage of platelets in additive solutions: the effect of citrate and acetate in in vitro studiesTransfusion, 1993
- Clinical Usefulness of Red Cells Preserved in Protein-Poor MediumsThe New England Journal of Medicine, 1978